Boris Peaker

Stock Analyst at TD Cowen

(2.10)
# 2,680
Out of 4,789 analysts
20
Total ratings
36.36%
Success rate
9.89%
Average return

Stocks Rated by Boris Peaker

GlycoMimetics
Jul 26, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.21
Upside: -
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.27
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $97.60
Upside: +2.46%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.41
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $24.85
Upside: +101.21%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $37.76
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $10.64
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30$29
Current: $4.86
Upside: +496.71%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.64
Upside: -
Nektar Therapeutics
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.68
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $10.11
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $591.87
Upside: -
Maintains: Market Perform
Price Target: $95$102
Current: $89.76
Upside: +13.64%
Downgrades: Market Perform
Price Target: n/a
Current: $0.87
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $1.38
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $0.65
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $0.34
Upside: -